These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6785360)

  • 21. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
    Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
    Veenema RJ; Dean AL; Uson AC; Roberts M; Longo F
    J Urol; 1969 May; 101(5):711-5. PubMed ID: 4976352
    [No Abstract]   [Full Text] [Related]  

  • 25. [Local administration of thio-tepa in the prevention of papillomatous neoplasms of the urinary bladder].
    Kaczmarek A
    Wiad Lek; 1977 Feb; 30(3):187-91. PubMed ID: 402747
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1975; 17(7-8):253-8. PubMed ID: 808781
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.
    Byar D; Blackard C
    Urology; 1977 Dec; 10(6):556-61. PubMed ID: 414402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytostatic topical therapy and prevention of recurrence in bladder papillomatosis].
    Lunglmayr G
    Wien Klin Wochenschr; 1971 Jul; 83(27):526-8. PubMed ID: 5001284
    [No Abstract]   [Full Text] [Related]  

  • 29. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection.
    Mitsumori K; Tsuchiya N; Habuchi T; Li Z; Akao T; Ohyama C; Sato K; Kato T
    BJU Int; 2004 Aug; 94(3):317-21. PubMed ID: 15291859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.
    Csellár M; Csontai A
    Int Urol Nephrol; 1979; 11(1):39-44. PubMed ID: 112079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adrianycin as intracavitary coadjuvant treatment of superficial bladder tumors. Our initial experiences].
    Martínez Lasierra M; Caro Cebrián C; Sanz Vélez JI; Roncalés A; Rioja Sanz C
    Actas Urol Esp; 1981; 5(4):219-22. PubMed ID: 6797270
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy in superficial neoplasms of the bladder.
    Zingg E; Sulmoni A
    S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of postoperative recurrence of bladder cancer: a clinical study].
    Yang D; Li S; Wang H; Li X; Liu S; Han W; Hao J; Zhang H
    Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):464-5. PubMed ID: 11829890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of treatments of bladder carcinoma: TUR, thiotepa or BCG].
    Rodrigues Netto Júnior N; Caserta Lemos G
    Arch Esp Urol; 1981; 34(5):369-74. PubMed ID: 6800309
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of thiotepa and adriamycin as preventive intravesical treatment in non-infiltrating bladder tumors].
    Lancina Martín JA; Mateo Cambón L; Casas Muiño RA; González Martín M
    Actas Urol Esp; 1983; 7(4):269-74. PubMed ID: 6414263
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thio-Tepa in the chemotherapy and chemical prevention of papillary neoplasms of the bladder].
    Delzotto L; Viggiano G; Marchini M; Barbui PE
    Minerva Med; 1977 Jun; 68(28):1957-60. PubMed ID: 406584
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
    Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X
    Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
    Matveev BP; Kariakin OB; Safiullin KN; Figurin KM; Levi DT; Vatin OE
    Urol Nefrol (Mosk); 1993; (5):27-9. PubMed ID: 8310581
    [No Abstract]   [Full Text] [Related]  

  • 39. The value of thiotepa in the treatment of superficial bladder tumors.
    Akdaş A; Kirkali Z; Sengör F; Ilker Y; Taşar C
    Turk J Pediatr; 1984; 26(1-4):243-50. PubMed ID: 6443167
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and experimental projects on chemotherapy of bladder tumours.
    Pavone-Macaluso M; Rausa L; Gebbia N; Caramia G; Rizzo FP; Arena E; Tessitore V; Vecchioni M
    S Afr Med J; 1974 Mar; 48(15):631-6. PubMed ID: 4378338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.